Total Payments
$36,054
2023 Payments
$98.61
Companies
7
Transactions
78
Medicare Patients
2,251
Medicare Billing
$158,867
Payment Breakdown by Category
Other$33,350 (92.5%)
Food & Beverage$1,427 (4.0%)
Travel$1,270 (3.5%)
Education$6.96 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $33,350 | 15 | 92.5% |
| Food and Beverage | $1,427 | 48 | 4.0% |
| Travel and Lodging | $1,270 | 14 | 3.5% |
| Education | $6.96 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $35,762 | 71 | $0 (2022) |
| Astellas Pharma US Inc | $124.99 | 1 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $98.61 | 2 | $0 (2023) |
| Myovant Sciences Inc. | $26.47 | 1 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $17.97 | 1 | $0 (2021) |
| TherapeuticsMD, Inc. | $12.08 | 1 | $0 (2019) |
| Radius Health, Inc. | $11.18 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $98.61 | 2 | Sumitomo Pharma America, Inc. ($98.61) |
| 2022 | $191.04 | 4 | Astellas Pharma US Inc ($124.99) |
| 2021 | $5,913 | 9 | AbbVie Inc. ($5,895) |
| 2020 | $6,066 | 8 | AbbVie Inc. ($6,066) |
| 2019 | $12,971 | 32 | AbbVie, Inc. ($12,959) |
| 2018 | $10,814 | 23 | AbbVie, Inc. ($10,803) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/16/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: HORMONE THERAPY | ||||||
| 09/28/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $81.27 | General |
| Category: HORMONE THERAPY | ||||||
| 12/01/2022 | ABBVIE INC. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: WOMENS HEALTH | ||||||
| 10/21/2022 | Myovant Sciences Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $26.47 | General |
| Category: HORMONE THERAPY | ||||||
| 10/13/2022 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 07/07/2022 | ABBVIE INC. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: WOMENS HEALTH | ||||||
| 12/04/2021 | AbbVie Inc. | ORIAHNN (Drug) | Education | In-kind items and services | $6.96 | General |
| Category: WOMENS HEALTH | ||||||
| 11/30/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $3.04 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.97 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/04/2021 | AbbVie Inc. | ORILISSA (Drug), ORIAHNN | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,950.00 | General |
| Category: WOMENS HEALTH | ||||||
| 08/20/2021 | AbbVie Inc. | ORILISSA (Drug), ORIAHNN | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: WOMENS HEALTH | ||||||
| 07/13/2021 | AbbVie Inc. | ORILISSA (Drug), ORIAHNN | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: WOMENS HEALTH | ||||||
| 06/23/2021 | AbbVie Inc. | ORILISSA (Drug), ORIAHNN | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,950.00 | General |
| Category: WOMENS HEALTH | ||||||
| 06/02/2021 | AbbVie Inc. | ORIAHNN (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,950.00 | General |
| Category: WOMENS HEALTH | ||||||
| 03/16/2021 | AbbVie Inc. | ORILISSA (Drug), ORIAHNN | Food and Beverage | In-kind items and services | $3.28 | General |
| Category: WOMENS HEALTH | ||||||
| 12/18/2020 | AbbVie Inc. | ORIAHNN (Drug), ORILISSA | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: WOMENS HEALTH | ||||||
| 11/11/2020 | AbbVie Inc. | ORILISSA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: WOMENS HEALTH | ||||||
| 11/09/2020 | AbbVie Inc. | ORILISSA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: WOMENS HEALTH | ||||||
| 10/19/2020 | AbbVie Inc. | ORILISSA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: WOMENS HEALTH | ||||||
| 08/28/2020 | AbbVie Inc. | ORIAHNN (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: WOMENS HEALTH | ||||||
| 03/06/2020 | AbbVie Inc. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: WOMENS HEALTH | ||||||
| 02/15/2020 | AbbVie Inc. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: WOMENS HEALTH | ||||||
| 01/31/2020 | AbbVie Inc. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: WOMENS HEALTH | ||||||
| 11/12/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $4.92 | General |
| Category: Endocrinology | ||||||
| 10/04/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 604 | 684 | $108,430 | $41,506 |
| 2022 | 9 | 611 | 676 | $104,525 | $41,991 |
| 2021 | 7 | 558 | 605 | $94,971 | $41,984 |
| 2020 | 7 | 478 | 532 | $87,492 | $33,386 |
Total Patients
2,251
Total Services
2,497
Medicare Billing
$158,867
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 128 | 139 | $38,225 | $12,451 | 32.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 70 | 70 | $10,500 | $9,369 | 89.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 26 | $7,800 | $3,649 | 46.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 38 | 71 | $12,425 | $3,203 | 25.8% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 71 | 71 | $5,325 | $3,164 | 59.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $6,300 | $2,840 | 45.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 67 | 67 | $4,355 | $2,807 | 64.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 32 | $8,000 | $2,142 | 26.8% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 12 | 15 | $6,750 | $1,284 | 19.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 154 | 175 | $8,750 | $596.75 | 6.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 138 | 157 | $43,075 | $13,356 | 31.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 94 | 94 | $14,600 | $12,914 | 88.5% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 79 | 79 | $5,925 | $3,633 | 61.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 80 | 80 | $5,200 | $3,448 | 66.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 19 | $5,750 | $2,904 | 50.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 36 | $9,000 | $2,233 | 24.8% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 12 | 17 | $7,650 | $1,688 | 22.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 21 | 29 | $5,075 | $1,248 | 24.6% |
| 81002 | Urinalysis, manual test | Office | 2022 | 143 | 165 | $8,250 | $565.88 | 6.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 137 | 166 | $45,039 | $16,298 | 36.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 107 | 107 | $21,877 | $15,134 | 69.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 75 | 75 | $6,325 | $3,506 | 55.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 74 | 74 | $5,050 | $3,166 | 62.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 12 | 12 | $3,640 | $1,713 | 47.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 25 | $5,864 | $1,659 | 28.3% |
About Dr. Barbara Soltes, M.D
Dr. Barbara Soltes, M.D is a Reproductive Endocrinology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164591301.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Barbara Soltes, M.D has received a total of $36,054 in payments from pharmaceutical and medical device companies, with $98.61 received in 2023. These payments were reported across 78 transactions from 7 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($33,350).
As a Medicare-enrolled provider, Soltes has provided services to 2,251 Medicare beneficiaries, totaling 2,497 services with total Medicare billing of $158,867. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Reproductive Endocrinology
- Location Chicago, IL
- Active Since 11/06/2006
- Last Updated 03/20/2015
- Taxonomy Code 207VE0102X
- Entity Type Individual
- NPI Number 1164591301
Products in Payments
- Orilissa (Drug) $17,029
- ORILISSA (Drug) $8,481
- Lupron (Drug) $6,718
- ORIAHNN (Drug) $3,477
- MYFEMBREE (Drug) $125.08
- LO LOESTRIN FE (Drug) $39.58
- LifeVest (Device) $17.97
- BIJUVA (Drug) $12.08
- Tymlos (Biological) $11.18
- SYNTHROID (Drug) $3.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Reproductive Endocrinology Doctors in Chicago
Dr. Angeline Beltsos, M.d, M.D
Reproductive Endocrinology — Payments: $152,443
Reproductive Endocrinology $152,443
Dr. Eve Feinberg, Md, MD
Reproductive Endocrinology — Payments: $118,427
Reproductive Endocrinology $118,427
Roohi Najeemuddin, M.d, M.D
Reproductive Endocrinology — Payments: $87,779
Reproductive Endocrinology $87,779
Ilan Tur-Kaspa, M.d, M.D
Reproductive Endocrinology — Payments: $21,754
Reproductive Endocrinology $21,754
Serdar Bulun, Md, MD
Reproductive Endocrinology — Payments: $14,624
Reproductive Endocrinology $14,624
Dr. Tarun Jain, M.d, M.D
Reproductive Endocrinology — Payments: $8,184
Reproductive Endocrinology $8,184